At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Morphine PCA +1 moredrug
Likely dose
Morphine PCA 1mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Comparison of Morphine and Hydromorphone Patient-Controlled Analgesia
In Brief
A Phase 4 clinical trial evaluating Morphine PCA and Hydromorphone PCA for Post Operative Pain. Completed, enrolled 50 participants across 1 site.
Detailed Summary
Both morphine and hydromorphone are pain medications commonly used after surgery. It is thought at the institution that hydromorphone causes less side effects but this has not been studied. The study proposes to treat the patients with either morphine or hydromorphone and determine how much nausea, vomiting, and itching they have with each drug
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Operative Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2003
First PostedOct 2006
Primary CompletionOct 2007
TodayJul 2026
First PostedOct 9, 2006
Enrollment StartNov 1, 2003
Primary CompletionOct 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 19.7 years ago
Interventions
Morphine PCAdrug
Morphine 1mg/mL, dose 1mL, lockout 6 minutes, max 10mL
Hydromorphone PCAdrug
hydromorphone PCA 0.2mg/lml, dose 1ml, lockout 6min, max 10ml